Strekin AG completes patient recruitment in RESTORE Ph3 of STR001

Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...

September 15, 2019 | Sunday | News
IBI303 results for Ankylosing Spondylitis published in "The Lancet Rheumatology”

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...

September 2, 2019 | Monday | News
Ascletis receives IND approval for its NASH drug

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...

August 28, 2019 | Wednesday | News
Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019

ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...

August 27, 2019 | Tuesday | News
First patient dosed for Phase I/II trial of avapritinib in advanced GIST

CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...

August 26, 2019 | Monday | News
New trial to evaluate an investigational drug for Parkinson's disease

Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...

August 26, 2019 | Monday | News
CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia

CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...

August 23, 2019 | Friday | News
Luye Pharma's anti-depression drug to start clinical trials in Japan

Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...

August 22, 2019 | Thursday | News
Janssen reports positive Ph3 results of long-acting injectable HIV treatment regimen

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results fr...

August 22, 2019 | Thursday | News
AstraZeneca announces positive results for heart drug candidate

AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that&n...

August 20, 2019 | Tuesday | News
CStone announces first patient dosed in China with BLU-667

CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I ...

August 13, 2019 | Tuesday | News
Jazz Pharma advances recombinant crisantaspase development program

Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...

August 8, 2019 | Thursday | News
DiscGenics treates First Patients in Japanese Clinical Trial of Cell Therapy for DDD

DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...

August 8, 2019 | Thursday | News
SillaJen to discontinue PHOCUS trial for advanced liver cancer

SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...

August 6, 2019 | Tuesday | News
"Improving trial efficiency and lowering trial costs is a big challenge"

Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...

August 5, 2019 | Monday | Opinion
Botanix receives commitments for A$40M in US-led institutional placement

Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...

August 5, 2019 | Monday | News
Veristat expands operations into Taiwan

US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...

August 1, 2019 | Thursday | News
CStone to initiate ivosidenib Phase I study in China

CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...

July 22, 2019 | Monday | News